Related Experiment Video
Updated: Nov 21, 2025
14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.9K
Biomimetic Drug Delivery Systems Oriented by Biological Function in Tumor Targeting
1Key Laboratory of Smart Drug Delivery, Ministry of Education, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, China.
Current Drug Targets
|January 18, 2021
Summary
Biomimetic nanoscale drug delivery systems offer a simpler, more effective approach to targeted chemotherapy delivery. These systems leverage natural biological functions for enhanced tumor targeting with reduced immunogenicity, improving clinical prospects.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Drug Delivery
Background:
- Nanoscale drug delivery systems show promise for targeted chemotherapy.
- Intelligent drug delivery systems are complex and hinder clinical translation.
- Biomimetic nanoscale systems integrate carrier properties with natural biological functions for tumor targeting.
Purpose of the Study:
- To classify and introduce biomimetic nanoscale drug delivery systems.
- To emphasize the unique biological functions of these systems.
- To highlight their advantages for tumor targeting.
Main Methods:
- Classification of biomimetic nanoscale drug delivery systems.
- Emphasis on their inherent biological functions.
- Analysis of their physicochemical properties and preparation methods.
Main Results:
- Biomimetic nanoscale drug delivery systems offer a simpler preparation process.
- These systems possess powerful functionalities for drug delivery.
- They exhibit low immunogenicity, enhancing their applicability.
Conclusions:
- Biomimetic nanoscale drug delivery systems present a promising avenue for advanced cancer therapy.
- Their simplified design and enhanced targeting capabilities facilitate clinical translation.
- The low immunogenicity and potent functions suggest broad application potential.
Related Concept Videos
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:26Targets for Drug Action: Overview
9.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.0K
01:24Principles of Drug Action
7.4K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
7.4K
01:27Tumor Immunotherapy
866
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
866
01:28Drug Products: Biologics, Biosimilars and Interchangeables
114
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
114
01:16Drug Biotransformation: Overview
3.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.3K